Martin J Edelman

Martin J Edelman

UNVERIFIED PROFILE

Are you Martin J Edelman?   Register this Author

Register author
Martin J Edelman

Martin J Edelman

Publications by authors named "Martin J Edelman"

Are you Martin J Edelman?   Register this Author

100Publications

2189Reads

30Profile Views

Differential Gene Expression in Erlotinib-Treated Fibroblasts.

Nurs Res 2019 Mar/Apr;68(2):110-126

Karen E. Wickersham, PhD, RN, was Assistant Professor, School of Nursing, University of Maryland, Baltimore; now Assistant Professor, University of South Carolina, College of Nursing, Columbia, South Carolina. Theresa K. Hodges, PhD, is Bioinformatics Analyst I, Institute for Genome Sciences, School of Medicine, University of Maryland, Baltimore, Maryland. Martin J. Edelman, MD, was Director, Medical Thoracic Oncology, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland; now Professor and Chair, Department of Hematology/Oncology; Deputy Director, Cancer Center for Clinical Research; and G. Morris Dorrance Jr. Chair in Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. Yang Song, PhD, is Bioinformatics Analyst II, Institute for Genome Sciences, School of Medicine, University of Maryland, Baltimore, Maryland. Mintong Nan, BS, was Laboratory Research Technician, Department of Pain and Translational Symptom Science, University of Maryland, Baltimore, School of Nursing, Baltimore, Maryland. Susan G. Dorsey, PhD, RN, FAAN, is Professor and Chair, Department of Pain and Translational Symptom Science, University of Maryland, Baltimore, School of Nursing, Baltimore, Maryland; and PhD Student at the University of Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NNR.0000000000000330DOI Listing
November 2019

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors.

Adv Ther 2019 Oct 13;36(10):2638-2678. Epub 2019 Aug 13.

Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-019-01051-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778545PMC
October 2019

Outcomes of patients with disease recurrence after treatment for locally advanced non-small cell lung cancer detected by routine follow-up CT scans versus a symptom driven evaluation.

Lung Cancer 2019 Sep 9;135:16-20. Epub 2019 Jul 9.

Fox Chase Cancer Center, Philadelphia, PA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.07.009DOI Listing
September 2019

Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infection.

Lung Cancer 2018 09 26;123:87-90. Epub 2018 Jun 26.

Johns Hopkins School of Medicine, 301 Mason Lord Drive, Suite 4500, Baltimore, MD, 21224, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.06.028DOI Listing
September 2018

Daily diary study of hope, stigma, and functioning in lung cancer patients.

Health Psychol 2018 03 27;37(3):218-227. Epub 2017 Nov 27.

Department of Hematology/Oncology Fox Chase Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1037/hea0000570DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837918PMC
March 2018

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).

J Clin Oncol 2017 Jul 10;35(19):2184-2192. Epub 2017 May 10.

Martin J. Edelman, University of Maryland Greenebaum Cancer Center, Baltimore, MD; Xiaofei Wang and Lydia Hodgson, Alliance Statistical and Data Center, Duke University; Thomas E. Stinchcombe, Duke University School of Medicine, Durham, NC; Richard T. Cheney, Roswell Park Cancer Institute, Buffalo; Ajeet Gajra, State University of New York Upstate Medical University, Syracuse, NY; Maria Q. Baggstrom, Washington University School of Medicine, St Louis, MO; Sachdev P. Thomas, Illinois Cancer Care, Peoria; Paula N. Friedman and Everett E. Vokes, University of Chicago; Olwen M. Hahn, Alliance Protocol Office, University of Chicago, Chicago, IL; Erin Bertino, The Ohio State University Medical Center, Columbus, OH; Karen L. Reckamp, City of Hope Comprehensive Cancer Center, Duarte, CA; Julian Molina, Mayo Clinic, Rochester; Jon Ritter, University of Minnesota, Minneapolis, MN; Joan H. Schiller, University of Texas Southwestern Medical Center, Dallas, TX; Kisha Mitchell-Richards, Yale University, New Haven, CT; and Ginger Milne, Vanderbilt University, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.3743DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493050PMC
July 2017

Highlights in the Treatment of Lung Cancer: What's New? Not Much.

Authors:
Martin J Edelman

JAMA Oncol 2017 03;3(3):301-302

University of Maryland Greenebaum Cancer Center, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.3984DOI Listing
March 2017

Whole-Brain Radiation in the Treatment of Brain Metastases in ALK-Positive Non-Small-Cell Lung Cancer.

J Clin Oncol 2017 03 28;35(7):809-810. Epub 2016 Dec 28.

Jason K. Molitoris, University of Maryland Medical Center, Baltimore, MD; Martin J. Edelman, University of Maryland Greenebaum Cancer Center, Baltimore, MD; and William F. Regine and Steven J. Feigenberg, University of Maryland School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.7227DOI Listing
March 2017

Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung.

J Clin Oncol 2017 Feb 12;35(4):412-420. Epub 2016 Dec 12.

David R. Spigel, Sarah Cannon Research Institute, Nashville, TN; Martin J. Edelman, University of Maryland Greenebaum Cancer Center, Baltimore, MD; Kenneth O'Byrne, Queensland University of Technology, Brisbane, Queensland, Australia; Luis Paz-Ares, Hospital Universitario Doce de Octubre and Centro Nacional de Investigaciones Oncológicas, Madrid, Spain; Simonetta Mocci, See Phan, David S. Shames, Dustin Smith, Wei Yu, and Virginia E. Paton, Genentech, South San Francisco, CA; and Tony Mok, Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.2160DOI Listing
February 2017

Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors.

Cancer Chemother Pharmacol 2016 Nov 12;78(5):959-967. Epub 2016 Sep 12.

University of Maryland School of Pharmacy, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-3148-xDOI Listing
November 2016

Prostaglandin E Receptor EP4 expression, survival and pattern of recurrence in locally advanced NSCLC.

Lung Cancer 2016 11 14;101:88-91. Epub 2016 Sep 14.

University of Maryland Marlene and Stewart Greenebaum Cancer Center, 22 South Greene Street, Baltimore, MD, 21201, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.09.011DOI Listing
November 2016

Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring system.

Bioorg Med Chem 2016 06 9;24(12):2595-602. Epub 2016 Mar 9.

Laboratory for Drug Design & Synthesis, Department of Chemistry & Biochemistry, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2016.03.015DOI Listing
June 2016

The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy.

Am J Clin Oncol 2016 Apr;39(2):136-41

Departments of *Radiation Oncology §Medical Oncology ∥Thoracic Surgery, University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD †Department of Radiation Oncology, University of Chicago, Chicago, IL ‡Department of Biostatistics, University of Pennsylvania School of Nursing, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613244PMC
April 2016

50 Years of progress in the systemic therapy of non-small cell lung cancer.

Am Soc Clin Oncol Educ Book 2014 :177-89

From the Stanford Cancer Institute, Stanford University, Stanford, CA; University of California, Davis Cancer Center, Sacramento, CA; University of New Mexico Cancer Center, Albuquerque, NM.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2014.34.177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600272PMC
November 2015

Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non-Small-Cell Lung Cancer.

J Thorac Oncol 2015 Oct;10(10):1421-9

*Department of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA; †Department of Internal Medicine, University of Maryland, College Park, MD; ‡Department of Oncology, Lombardi Comprehensive Cancer Center of the Georgetown University, Washington, DC; §Department of Biostatistics, University of California, Davis, CA; ‖Division of Medical Oncology, Swedish Cancer Institute, Seattle, WA; ¶Department of Internal Medicine, Swedish Cancer Institute, Seattle, WA; #Department of Internal Medicine, Comprehensive Cancer Center, University of California, Davis, CA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153351
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000508DOI Listing
October 2015

A piRNA-like small RNA interacts with and modulates p-ERM proteins in human somatic cells.

Nat Commun 2015 Jun 22;6:7316. Epub 2015 Jun 22.

1] Department of Oncology and Diagnostic Sciences, University of Maryland School of Dentistry, 650W Baltimore Street, Baltimore, Maryland 21201, USA [2] Marlene and Stewart Greenebaum Cancer Center, University of Maryland, 22S Greene Street, Baltimore, Maryland 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms8316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557300PMC
June 2015

Assessing functional status and the survival benefit of chemotherapy for advanced non-small cell lung cancer using administrative claims data.

Lung Cancer 2015 Jan 13;87(1):59-64. Epub 2014 Nov 13.

University of Maryland, Greenebaum Cancer Center, 22 South Greene Street, Baltimore, MD 21201, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002140044
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2014.10.011DOI Listing
January 2015

Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer.

J Clin Oncol 2015 Jan 1;33(2):189-94. Epub 2014 Dec 1.

Martin J. Edelman, Josephine Feliciano, Yang Yang, and Michelle Medeiros, University of Maryland Greenebaum Cancer Center, Baltimore, MD; Ming T. Tan, Georgetown University, Washington, DC; Mary J. Fidler, Rush University Medical Center, Chicago, IL; Rachel E. Sanborn, Providence Portland Medical Center, Portland, OR; Greg Otterson, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Lecia V. Sequist, Massachusetts General Hospital Cancer Center, Boston, MA; Tracey L. Evans, University of Pennsylvania, Philadelphia, PA; Bryan J. Schneider, Weill Cornell Medical College, New York City; Roger Keresztes, State University of New York Stony Brook, Stony Brook, NY; John S. Rogers, West Virginia University School of Medicine, Morgantown, WV; Jorge Antunez de Mayolo, Mercy Research Institute, Miami, FL; and Sara L. Zaknoen, Tragara, San Diego, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.5789DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890680PMC
January 2015

GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinoma.

Hum Pathol 2014 Sep 5;45(9):1893-9. Epub 2014 Jun 5.

A&G Pharmaceutical, Columbia MD 21045; University of Maryland, Greenebaum Cancer Center, Baltimore, MD 21201. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2014.05.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150823PMC
September 2014

Validation of disability status, a claims-based measure of functional status for cancer treatment and outcomes studies.

Med Care 2014 Jun;52(6):500-10

*Agency for Healthcare Research and Quality, Rockville, MD †Epidemiology and Public Health, School of Medicine ‡IMPAQ International, LLC, Columbia, MD §Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD ∥School of Medicine, University of New Mexico, Albuquerque, NM.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MLR.0000000000000122DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256940PMC
June 2014

Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancer.

J Thorac Oncol 2014 Jan;9(1):121-5

*H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida; †Arlington Cancer Center, Arlington, Texas; ‡Mayo Clinic Arizona, Scottsdale, Arizona; §Georgetown University Hospital, Washington, District of Columbia; ‖University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland; ¶Tower Cancer Research Foundation, Beverly Hills, California; #MedStar Research Institute, Hyattsville, Maryland; and **formerly Gemin X Pharmaceuticals, an indirect wholly owned subsidiary of Teva Pharmaceutical Industries Ltd., Petach Tikva, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666503PMC
January 2014

Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study.

J Clin Oncol 2013 Sep 26;31(27):3320-6. Epub 2013 Aug 26.

Glenwood D. Goss and Ian Lorimer, Ottawa Hospital Cancer Center, University of Ottawa, Ottawa; Chris O'Callaghan and Keyue Ding, NCIC CTG, Queens University, Kingston; Ming-Sound Tsao and Frances A. Shepherd, University Health Network, Princess Margaret Hospital, University of Toronto, Toronto; Jonathan Noble, Northeast Cancer Center, Sudbury, Ontario; Charles Butts, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada; Gregory A. Masters, Christiana Care's Helen F. Graham Cancer Center, Newark, DE; James Jett, National Jewish Health, Division of Oncology, Denver, CO; Martin J. Edelman, Greenebaum Cancer Center, University of Maryland, Baltimore, MD; Rogerio Lilenbaum, Smilow Cancer Hospital, Yale Cancer Center, New Haven, CT; Hak Choy, Kemp Kernstine, and Joan Schiller, The University of Texas, Southwestern Medical Center, Dallas; Katherine Pisters, The University of Texas MD Anderson Cancer Center, Houston, TX; Fadlo Khuri, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA; David Gandara, University of California, Davis Cancer Center, Sacramento, CA; Thomas A. Hensing, NorthShore University Health System, The University of Chicago, Chicago; and Kendrith Rowland, Carle Cancer Center, Urbana, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.1816DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770864PMC
September 2013

Resistance to anti-angiogenic agents: a brief review of mechanisms and consequences.

Transl Lung Cancer Res 2013 Aug;2(4):304-7

University of Maryland School of Dentistry, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2013.01.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367613PMC
August 2013

Anti-HDGF targets cancer and cancer stromal stem cells resistant to chemotherapy.

Clin Cancer Res 2013 Jul 21;19(13):3567-76. Epub 2013 May 21.

Department of Oncology and Diagnostic Sciences, University of Maryland School of Dentistry, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-3478DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707124PMC
July 2013

CDC25A(Q110del): a novel cell division cycle 25A isoform aberrantly expressed in non-small cell lung cancer.

PLoS One 2012 5;7(10):e46464. Epub 2012 Oct 5.

Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland Baltimore, Baltimore, Maryland, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0046464PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465328PMC
April 2013

Structure-based drug design and potent anti-cancer activity of tricyclic 5:7:5-fused diimidazo[4,5-d:4',5'-f][1,3]diazepines.

Bioorg Med Chem 2013 Feb 11;21(3):618-31. Epub 2012 Dec 11.

Laboratory for Drug Design & Synthesis, Department of Chemistry & Biochemistry, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2012.11.050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546142PMC
February 2013

Stereotactic Ablative Radiotherapy (SABR): Impact on the Immune System and Potential for Future Therapeutic Modulation.

Mol Cell Pharmacol 2013 Jan;5(1):19-25

Department of Radiation Oncology, University of Maryland School of Medicine, and the Greenebaum Cancer Center, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128167PMC
January 2013

Maintenance therapy and advanced non-small-cell lung cancer: a skeptic's view.

J Thorac Oncol 2012 Sep;7(9):1331-6

Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182629e37DOI Listing
September 2012

Epothilones in development for non--small-cell lung cancer: novel anti-tubulin agents with the potential to overcome taxane resistance.

Clin Lung Cancer 2012 May 19;13(3):171-80. Epub 2011 May 19.

University of Maryland Greenebaum Cancer Center, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152573041100040
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2011.02.005DOI Listing
May 2012

EC145: a novel targeted agent for adenocarcinoma of the lung.

Expert Opin Investig Drugs 2012 May 30;21(5):755-61. Epub 2012 Mar 30.

Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2012.671294DOI Listing
May 2012

EML4/ALK and ras inhibitors.

Authors:
Martin J Edelman

J Thorac Oncol 2010 Dec;5(12 Suppl 6):S495-6

University of Maryland Greenebaum Cancer Center, Baltimore, Maryland 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.JTO.0000391381.40050.5cDOI Listing
December 2010

Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System.

ACS Med Chem Lett 2010 Dec;2(3):252-256

Laboratory for Drug Design & Synthesis, Department of Chemistry & Biochemistry, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland, 21250, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/ml100281bDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092706PMC
December 2010

A novel, broad-spectrum anticancer compound containing the imidazo[4,5-e][1,3]diazepine ring system.

Bioorg Med Chem Lett 2010 Aug 15;20(15):4386-9. Epub 2010 Jun 15.

Laboratory for Drug Design and Synthesis, Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, Baltimore, Maryland 21250, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2010.06.061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905507PMC
August 2010

Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer.

J Clin Oncol 2010 May 29;28(13):2191-7. Epub 2010 Mar 29.

Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland Baltimore, 220 Arch St, 12th Floor, Room 214, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.25.4052DOI Listing
May 2010

Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancer.

Lung Cancer 2010 Apr 21;68(1):84-8. Epub 2009 Jun 21.

University of Maryland Greenebaum Cancer Center, 22 S Greene Street, Baltimore, MD 21201, United States of America.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016950020900267
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2009.05.003DOI Listing
April 2010

Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiation.

Ann Thorac Surg 2010 Jan;89(1):200-6; discussion 206

St. Joseph Cancer Institute, Towson, University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland 21204, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2009.08.069DOI Listing
January 2010

Targeted radiopharmaceutical therapy for advanced lung cancer: phase I trial of rhenium Re188 P2045, a somatostatin analog.

J Thorac Oncol 2009 Dec;4(12):1550-4

University of Maryland Greenebaum Cancer Center, Baltimore, Maryland 21201-1595, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181bf1070DOI Listing
December 2009

Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemias.

Clin Cancer Res 2009 Mar 17;15(5):1698-707. Epub 2009 Feb 17.

Program in Experimental Therapeutics, University of Maryland Marlene and Stewart Greenebaum Cancer Center, and Division of Hematology and Oncology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1587DOI Listing
March 2009

Novel taxane formulations and microtubule-binding agents in non-small-cell lung cancer.

Authors:
Martin J Edelman

Clin Lung Cancer 2009 Mar;10 Suppl 1:S30-4

University of Maryland, Greenebaum Cancer Center, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2009.s.005DOI Listing
March 2009

Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells.

Cancer Immunol Immunother 2008 Oct 6;57(10):1493-504. Epub 2008 Mar 6.

Department of Biological Sciences, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-008-0490-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805175PMC
October 2008

Pemetrexed-induced typhlitis in non-small cell lung cancer.

J Thorac Oncol 2008 Oct;3(10):1188-90

Department of Internal Medicine, University of Maryland, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318187490cDOI Listing
October 2008

Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery.

Int J Radiat Oncol Biol Phys 2008 Sep 14;72(1):19-23. Epub 2008 Feb 14.

Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.12.031DOI Listing
September 2008

Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer.

Ann Thorac Surg 2008 Sep;86(3):903-10

Division of Medical Oncology, University of Maryland School of Medicine and University of Maryland Greenebaum Cancer Center, Baltimore, Maryland 21201, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000349750801330
Publisher Site
http://dx.doi.org/10.1016/j.athoracsur.2008.06.022DOI Listing
September 2008

Successful treatment of small cell lung cancer during pregnancy.

Lung Cancer 2008 Jul 1;61(1):129-30. Epub 2008 Feb 1.

University of Maryland, Department of Internal Medicine, MD 21201, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2007.10.007DOI Listing
July 2008

Cancer stem cells and individualized therapy.

Cancer Genomics Proteomics 2007 May-Jun;4(3):165-74

Department of Medicine, University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
November 2007

Optimal duration of chemotherapy in advanced non-small cell lung cancer.

Curr Treat Options Oncol 2007 Feb;8(1):38-46

University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-007-0020-6DOI Listing
February 2007